-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Opinion|Videos|April 9, 2024

Desired Technology Innovations to Prevent Cardiovascular Disease

Panelists discuss desired innovations in health care technology, as well as incentives to further integrate these new technologies into patient care.


Related to this article

Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.